Phase II clinical and molecular trial of oral ENMD-2076 in clear cell ovarian cancer (CCOC): A study of the Princess Margaret phase II consortium.

被引：7

作者：

Lheureux, Stephanie

Burnier, Julia V.

Tan, Qian

Kanjanapan, Yada

Clarke, Blaise

Tinker, Anna

Ghatage, Prafull

Dhani, Neesha C.

Butler, Marcus .

Welch, Stephen

Weberpals, Johanne Ingrid

Tan, David Shao Peng

Brooks, Kelly

Ramsahai, Janelle

Wang, Lisa

Shaw, Patricia Ann

Tsao, Ming Sound

Garg, Swati

Stockley, Tracy

Oza, Amit M.

机构：

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.5522

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5522

引用

页数：4